Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy including surgery, irradiation, and chemotherapy.
Edaravone shows promise in targeting brain tumor stem cells
- Post author:
- Post published:October 17, 2024
- Post category:uncategorized
- Post comments:0 Comments